## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract
- **Shared manuscript claim summary** A general-purpose LLM agent, under human supervision and a fixed budget, iteratively developed an RNA 3D structure prediction model (QuickFold) over 297 iterations, matching the performance of strong open-source baselines (RhoFold+, NuFold) on lDDT and TM-score at lower inference cost.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or results sections provided.
- **Missing materials affecting confidence** Full manuscript (methods, results, figures, tables, code, data, baseline comparisons, statistical details, agent architecture, human supervision protocol, budget definition, iteration logs, and test set details) is absent. Confidence in assessing the claims is severely limited.

## Reviewer
- **Overall assessment** The abstract presents an intriguing concept—using an LLM agent to drive semi-autonomous model development for a challenging biological problem. The reported outcome (matching strong baselines at lower cost) is potentially significant. However, the abstract alone provides insufficient detail to evaluate the validity, reproducibility, or novelty of the work. Critical information about the agent’s architecture, the human supervision loop, the training process, the evaluation protocol, and the statistical rigor of the comparisons is missing. The claim of “matching” baselines “within noise” is vague without effect sizes, confidence intervals, or a clear definition of the noise threshold. The framing as a “case study” is appropriate, but the evidence base is too thin to support even that.

- **Who would be interested in the results, and why** Researchers in computational structural biology, RNA bioinformatics, and AI-driven scientific discovery would be interested. The work suggests a new paradigm for automated model development, potentially reducing the human effort required to build competitive predictors. The low inference cost of QuickFold could also be of practical interest.

- **Major strengths** 
    - The core idea—using an LLM agent to iteratively improve a model for a hard biological problem—is novel and timely.
    - The reported outcome (matching strong baselines) is ambitious and, if true, would be a significant demonstration of agent-driven development.
    - The explicit framing as a case study, rather than a new state-of-the-art predictor, is honest and appropriate.

- **Major Concerns**
    - **Concern ID** R1-M1
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Reproducibility & Methodology
    - **Claim pointer** “the agent iteratively proposed, implemented, trained, and evaluated model changes”
    - **Evidence pointer** Abstract only; location not provided
    - **Concern** The abstract provides no details on the agent’s architecture (e.g., which LLM, how it was prompted, how it accessed code and data), the human supervision protocol (what decisions were made by the human vs. the agent), or the “fixed budget” (compute, time, or monetary cost). Without this, the work cannot be reproduced or even properly understood.
    - **Why it matters** The core claim of “agent-driven” development hinges on the autonomy and capability of the agent. If the human role was extensive, the claim is weakened. Reproducibility is a fundamental requirement for any scientific claim.
    - **Resolution test** Provide a detailed description of the agent architecture, the human-in-the-loop protocol, and the budget constraints in the full manuscript.

    - **Concern ID** R1-M2
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Statistical Rigor & Evaluation
    - **Claim pointer** “matches the strongest open-source baselines (RhoFold+, NuFold) on lDDT and TM-score within noise on a held-out test set”
    - **Evidence pointer** Abstract only; location not provided
    - **Concern** The phrase “within noise” is undefined. What is the noise level? Is it the standard deviation of the metric across multiple runs? The variance of the baseline? The abstract does not report numerical values, confidence intervals, or statistical tests. “Matching” could mean anything from statistically indistinguishable to practically similar but significantly different.
    - **Why it matters** The central performance claim is unverifiable without proper statistical reporting. This is a critical flaw for a claim that positions the model as competitive with established methods.
    - **Resolution test** Report mean and standard deviation (or confidence intervals) for lDDT and TM-score for QuickFold and each baseline on the held-out test set. Perform a statistical test (e.g., paired t-test or bootstrap) to support the “within noise” claim. Define the noise threshold explicitly.

    - **Concern ID** R1-M3
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Novelty & Attribution
    - **Claim pointer** “We frame this less as a new predictor than as a case study in feedback-driven, agent-led model development”
    - **Evidence pointer** Abstract only; location not provided
    - **Concern** The abstract does not clarify what, if any, novel architectural or algorithmic components were discovered by the agent. If QuickFold is simply a re-implementation or minor variation of existing architectures, the novelty of the case study is limited to the process, not the product. The abstract also does not cite or discuss prior work on automated machine learning (AutoML), neural architecture search (NAS), or LLM agents for code generation, making it impossible to assess the novelty of the approach.
    - **Why it matters** The contribution is framed as a case study, but its value depends on whether the process led to non-trivial insights or a genuinely novel model. Without comparison to existing automated methods, the novelty is unclear.
    - **Resolution test** In the full manuscript, clearly describe the architectural innovations (if any) introduced by the agent. Compare the agent-driven process to existing AutoML/NAS approaches and discuss what was learned about the problem.

- **Minor Comments**
    - **Concern ID** R1-m1
    - **Severity** Minor
    - **Axis** Clarity
    - **Affected element** Claim about “fraction of their inference cost”
    - **Evidence pointer** Abstract only; location not provided
    - **Issue** The abstract does not quantify the inference cost (e.g., FLOPs, runtime, memory) for QuickFold or the baselines. “Fraction” is vague.
    - **Required correction** Report the specific inference cost metric and the ratio (e.g., “QuickFold requires 0.3× the FLOPs of RhoFold+”).

    - **Concern ID** R1-m2
    - **Severity** Minor
    - **Axis** Completeness
    - **Affected element** Description of the development loop
    - **Evidence pointer** Abstract only; location not provided
    - **Issue** The abstract mentions “297 iterations” but does not describe the success rate, the types of changes proposed, or the trajectory of model performance over time.
    - **Required correction** In the full manuscript, include a plot of performance vs. iteration number and a summary of the types of changes made (e.g., architecture, hyperparameters, training data).

- **Technical failings that need to be addressed before the case is established** R1-M1 (reproducibility of agent-driven process), R1-M2 (statistical rigor of performance claim), R1-M3 (novelty and attribution).

- **Assessment against Nature-style criteria**
    - **Originality**: The concept of using an LLM agent for iterative model development in RNA structure prediction is novel. However, the abstract does not demonstrate that the process led to a genuinely new architecture or insight, which is needed to establish originality beyond the method itself.
    - **Scientific importance**: If validated, the work could demonstrate a new paradigm for automated scientific discovery in a hard biological problem. This is potentially important, but the current evidence is insufficient.
    - **Interdisciplinary readership**: The topic bridges AI, structural biology, and RNA bioinformatics, which is of broad interest. The abstract is written in a way that is accessible to nonspecialists.
    - **Technical soundness**: The abstract lacks the technical detail needed to assess soundness. The statistical claim is vague, and the methodology is opaque. This is a critical weakness.
    - **Readability for nonspecialists**: The abstract is clear and well-written, avoiding unnecessary jargon. The framing as a case study helps.

- **Recommendation posture** Currently not established from the provided evidence. The abstract presents an intriguing idea, but the lack of methodological detail, statistical rigor, and novelty attribution means the claims cannot be evaluated. A full manuscript with detailed methods, results, and comparisons is required before a meaningful assessment can be made.

## Risk / unsupported claims
- The claim that QuickFold “matches” RhoFold+ and NuFold “within noise” is unsupported due to the lack of numerical data and statistical analysis.
- The claim that the development was “agent-driven” is unsupported without a detailed description of the human supervision protocol and agent architecture.
- The claim of “lower inference cost” is unsupported without quantitative metrics.
- The novelty of the agent-driven process relative to existing AutoML/NAS approaches cannot be assessed.